HighGravityData
Companies / Stryker / Filing

Stryker — Jul 31, 2025 release

Fiscal 2025 second-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000310764-25-000103
Open on SEC.gov ↗
Showing in the filing
Organic net sales growth
“9.5% to 10.0%”
Period
FY2025
Measure
Company-defined measure
Source
Prose
All guidance in this release · 3
Organic net sales growth for FY2025
“9.5% to 10.0%”
Adjusted net earnings per diluted share for FY2025
“$13.40 to $13.60”
Net impact from tariffs for FY2025
“approximately $175 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Adjusted net earnings per diluted share (1) of $3.13 increased 11.4% in the quarter. 2025 Outlook Considering our year-to-date results, strong demand for our products and our operational momentum, we are raising our full year 2025 guidance and now expect organic net sales growth (2) of 9.5% to 10.0% and adjusted net earnings per diluted share (2) to be in the range of $13.40 to $13.60. Our updated sales guidance includes a modestly favorable pricing impact. In addition, foreign exchange is expected to have a slightly positive impact on both sales and adjusted net earnings per diluted share (2) should rates hold near current levels. We now estimate a net impact from tariffs in 2025 of approximately $175 million. This estimate reflects the latest updates since the date of our last earnings press release, including a reduction in bilateral United States and China tariffs as well as the recent announcement of the proposed tariff framework between the United States and the European Union. 1 (1) A reconciliation of the non-GAAP financial measures: adjusted gross profit margin, adjusted operating income and adjusted operating income margin, adjusted net earnings and adjusted net earnings per diluted share, to the most directly comparable GAAP measures: gross profit margin, operating income and operating income margin, net earnings and net earnings per diluted share, and other important information accompanies this press release. (2) We are unable to present a quantitative reconcilia
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.